Christopher J. Patriquin
199-435 St Laurent Blvd
Ottawa, ON, Canada
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Neurological Impact of Caplacizumab in Refractory iTTP Survivors: A Comparative Study of Blood-Brain-Barrier Integrity and Cognitive Outcomes.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 07, 2026
Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and Canada.
Journal: Hematology (Amsterdam, Netherlands)
Published: January 02, 2026
The varieties of therapeutic experience: navigating treatment options for patients with PNH.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry.
Journal: American journal of hematology
Published: October 16, 2025
Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease.
Journal: Journal of blood medicine
Published: September 07, 2025
Endothelial Injury to Cognitive Decline: A 12-month Follow-up Using CT-Perfusion and Diffusion MRI in Immune-mediated Thrombotic Thrombocytopenic Purpura.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 03, 2025
Endothelial injury to cognitive decline: a 12-month follow-up using computed tomography perfusion and diffusion magnetic resonance imaging in immune-mediated thrombotic thrombocytopenic purpura.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 03, 2025
What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?
Journal: Annals of hematology
Published: February 24, 2025
Last Updated: 09/26/2026